| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18424894 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 107 journal articles in the PubMed database | Email to a friend | | |
| Rossi D, Catalano G
Pyridoxine as Prophylactic Therapy for Palmar-Plantar Erythrodysesthesia Associated with Administration of Pegylated Liposomal Doxorubicin (Caelyx): A Single-Center Experience. [LETTER]
Oncology 2008 Apr 17; 73(3-4):277-278.
Full Citation | Find Related Articles | | Mrochen-Domin I, Nowara E, Kaleta B
["Hand-foot" syndrome--after liposomal pegylated doxorubicin in patients with the ovarian cancer recurrence (own experiences)] [English Abstract, Journal Article]
Ginekol Pol 2008 May; 79(5):332-7.
Abstract | Full Citation | | Mangili G, Petrone M, Gentile C, et al.
Prevention strategies in palmar-plantar erythrodysesthesia onset: The role of regional cooling. [JOURNAL ARTICLE]
Gynecol Oncol 2007 Dec 14.
Abstract | Full Citation | Find Related Articles | | Gordinier ME, Dizon DS, Fleming EL, et al.
Elevated body mass index does not increase the risk of palmar-plantar erythrodysesthesia in patients receiving pegylated liposomal doxorubicin. [JOURNAL ARTICLE]
Gynecol Oncol 2006 Feb 20.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Palaia I, Angioli R, Bellati F, et al.
Distal phalange necrosis: A severe manifestation of palmar plantar erythrodysesthesia. [JOURNAL ARTICLE]
Am J Obstet Gynecol 2006 Jul 25.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Al-Batran SE, Meerpohl HG, von Minckwitz G, et al.
Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer. [Journal Article]
Oncology 2006; 70(2):141-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Molpus KL, Anderson LB, Craig CL, et al.
The effect of regional cooling on toxicity associated with intravenous infusion of pegylated liposomal doxorubicin in recurrent ovarian carcinoma. [Journal Article]
Gynecol Oncol 2004 May; 93(2):513-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tomb R, Stephan F, Halaby G
[Liposomal doxorubicin and palmoplantar erythrodysesthesia] [Case Reports, Letter]
Ann Dermatol Venereol 2003 Nov; 130(11):1057-8.
Full Citation | Publisher Full Text | Find Related Articles | | von Moos R, Thuerlimann BJ, Aapro M, et al.
Pegylated liposomal doxorubicin-associated hand-foot syndrome: Recommendations of an international panel of experts. [JOURNAL ARTICLE]
Eur J Cancer 2008 Mar 8.
Abstract | Full Citation |   |
|
| |
Advertise on this site.
|
